[go: up one dir, main page]

FI924576A0 - Ctaa 28a32, antigen identiefierad av mca 28a32 - Google Patents

Ctaa 28a32, antigen identiefierad av mca 28a32

Info

Publication number
FI924576A0
FI924576A0 FI924576A FI924576A FI924576A0 FI 924576 A0 FI924576 A0 FI 924576A0 FI 924576 A FI924576 A FI 924576A FI 924576 A FI924576 A FI 924576A FI 924576 A0 FI924576 A0 FI 924576A0
Authority
FI
Finland
Prior art keywords
antigen
epitope
mca
identiefierad
ctaa
Prior art date
Application number
FI924576A
Other languages
English (en)
Other versions
FI924576L (fi
Inventor
Nicholas Pomato
Ebo Sybren Bos
Janet Hazel Ransom
Michael George Hanna
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI924576A0 publication Critical patent/FI924576A0/fi
Publication of FI924576L publication Critical patent/FI924576L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
FI924576A 1990-04-12 1992-10-09 Ctaa 28a32, antigen identiefierad av mca 28a32 FI924576L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50837390A 1990-04-12 1990-04-12
PCT/US1991/002459 WO1991016629A1 (en) 1990-04-12 1991-04-10 Ctaa 28a32, the antigen recognized by mca 28a32

Publications (2)

Publication Number Publication Date
FI924576A0 true FI924576A0 (fi) 1992-10-09
FI924576L FI924576L (fi) 1992-10-09

Family

ID=24022500

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924576A FI924576L (fi) 1990-04-12 1992-10-09 Ctaa 28a32, antigen identiefierad av mca 28a32

Country Status (12)

Country Link
EP (1) EP0537168B1 (fi)
JP (1) JPH05507470A (fi)
KR (1) KR100206061B1 (fi)
AT (1) ATE138200T1 (fi)
AU (1) AU660927B2 (fi)
CA (1) CA2079601A1 (fi)
DE (1) DE69119591T2 (fi)
DK (1) DK0537168T3 (fi)
ES (1) ES2090331T3 (fi)
FI (1) FI924576L (fi)
GR (1) GR3020387T3 (fi)
WO (1) WO1991016629A1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69227380T3 (de) * 1991-11-12 2007-01-11 Prana Biotechnology Ltd., South Melbourne Verfahren zur bestimmung und behandlung von alzheimer-krankheit
US6387697B1 (en) 1998-12-28 2002-05-14 Corixa Corporation Compositions for treatment and diagnosis of breast cancer and methods for their use
US6969518B2 (en) 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
EP1248800A2 (en) 1999-11-30 2002-10-16 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
WO2001073027A2 (en) * 2000-03-24 2001-10-04 Corixa Corporation Compositions and methods for therapy and diagnosis of colon cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210867A (en) * 1984-01-31 1989-01-06 Litton Bionetics Inc Tumour-specific monoclonal antibodies, production thereof and use
DK172686A (da) * 1985-04-22 1986-10-23 Hybritech Inc Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet
EP0328578B1 (en) * 1987-07-02 1996-05-08 Akzo Nobel N.V. Antigen recognized by mca 16-88

Also Published As

Publication number Publication date
ES2090331T3 (es) 1996-10-16
DK0537168T3 (da) 1996-09-02
CA2079601A1 (en) 1991-10-13
EP0537168B1 (en) 1996-05-15
KR100206061B1 (ko) 1999-07-01
GR3020387T3 (en) 1996-09-30
ATE138200T1 (de) 1996-06-15
DE69119591T2 (de) 1996-09-12
JPH05507470A (ja) 1993-10-28
FI924576L (fi) 1992-10-09
AU660927B2 (en) 1995-07-13
DE69119591D1 (de) 1996-06-20
EP0537168A4 (en) 1993-05-05
EP0537168A1 (en) 1993-04-21
AU7788491A (en) 1991-11-11
WO1991016629A1 (en) 1991-10-31

Similar Documents

Publication Publication Date Title
DE69230545D1 (de) Antikörperderivate
NO994983D0 (no) Fremgangsmåte for fremstilling av anti-humane antigenreseptorer, samt anvendelse av disse
MX9701859A (es) Anticuerpos monoclonales en contra de antigenos asociados con carcinoma de colon humano, y usos de los mismos.
ATE154642T1 (de) Monoklonale antikörper gegen das mikrotubulusassoziierte protein tau.
ES539987A0 (es) Un procedimiento para preparar un anticuerpo monoclonal hu- mano
FI941758A0 (fi) Rekombitooppipeptidejä
FI900230A0 (fi) Anti-idiotypa antikroppar mot antikroppar mot antigener med hoeg molekylvikt associerade till human melanoma.
AU625171B2 (en) Specific excretion-secretion antigens of toxoplasma gondii, their expression products, processes for obtaining them and their diagnostic and prophylactic uses
FI924576A0 (fi) Ctaa 28a32, antigen identiefierad av mca 28a32
DK102589D0 (da) Antigen, der genkendes af mca 16-88
EP0420848A4 (en) Carcinoma-associated antigens, and antibodies which recognize these antigens
DE69229829D1 (de) Tumorspezifischer monoklonaler antikörper 81av78
DE3784364D1 (de) Tumorassoziiertes antigen.
NO924803L (no) Tumor-relatert monoklonalt antistoff 88bv59
Cronin Reactivity of antibodies isolated from immune complexes present in malignant effusions.
BG50103A1 (en) Hybridome cell line, secretting monoclonal antibody against antigene determinante noc- 2 of malignant melanom in human
DK182188A (da) Humant tumorassocieret antigen
ATE73234T1 (de) Anti-parathyroid-antikoerper-praeparat.
ATE95426T1 (de) Humanes karcinom-assoziertes antigen und an dieses antigen bindende antikoerper.